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DEAN’S RESEARCH NEWSLETTER                          Spring 2020
I am particularly gratified to witness the innovative research underway here at New York Medical 
College (NYMC). As we face this enormous health crisis, it is through research that we will 
advance all of the countries around the world in developing new treatments for COVID-19 and 
other serious health issues facing our nation. That is why I am proud to see so many timely 
research projects already taking place here for, as we know, research drives clinical practice. 
News of some of that invaluable research being conducted by our faculty and students, is 
included in this newsletter. I look forward to sharing more updates in future issues. 
Facilitating research is very important for both our faculty and students. Christopher S. Leonard, 
Ph.D., professor of physiology, is chairing the Research Support Services Committee, which will 
be working to identify how we can further support research. The Committee recently conducted 
a survey of our faculty to gain their vital input as we seek ways to improve the research and 
scholarship environment at NYMC. 
Congratulations to everyone as you continue your research, collaborations and success in securing grants. Be safe and well.
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COVID-19 RESEARCH
NYMC Collaborates with Regeneron for COVID-19 Clinical Drug Trials
When COVID-19 first hit our shores with no vaccine nor proven 
drug treatment in sight, new innovative collaborations sprouted up 
across the nation, as leading research institutions, pharmaceutical 
companies and hospitals joined forces to find a solution fast. Among 
them—a collaborative clinical drug trial by NYMC and Regeneron 
Pharmaceuticals launched at Westchester Medical Center (WMC) within 
the first few weeks. Seeking a partner with whom to establish a clinical 
drug trial that could be used to treat critically ill patients with COVID-19, 
Regeneron proposed the collaboration—not only for NYMC’s state-of-
the-art virology labs and internationally regarded experts—but because 
of the College’s decades-long involvement in the annual development of 
the influenza vaccine.
“As a result of COVID-19, people from across all sectors are coming together to help drive efforts to find a treatment and stop 
the virus.” says Salomon Amar, D.D.S., Ph.D., vice president for research at NYMC and provost for biomedical research at Touro 
College and University System (TCUS). “In any situation, wherever there is darkness—any negative impact—there is always 
some light. For the COVID-19 crisis, this new collaborative spirit represents that light.” Read full article on the clinical drug trials.
Medical Student Part of Project to Test NYC Subways for COVID-19 
Rising fourth-year medical student Ebrahim Afshinnekoo’s passion 
for research has long been in evidence. So it came as no surprise that 
when the COVID-19 pandemic hit New York. Mr. Afshinnekoo rose to 
the occasion as part of a team to test New York City (NYC) hospitals 
and urban environments for the prevalence of severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) and other viruses and to address 
the limitations in testing. 
“It was an ‘all hands on deck’ situation in the lab, and I jumped at the 
opportunity to do my part,” says Mr. Afshinnekoo. “With clinical rotations 
suspended, I wasn’t able to help support our health care workers on the 
front lines, but I was able to help fight the pandemic through this research.” 
It was during his undergraduate years at Macaulay Honors College at the City University of New York (CUNY) - Queens College 
that Mr. Afshinnekoo first began working with Christopher Mason, Ph.D., associate professor at Weill Cornell Medicine, on a project 
to collect DNA from the NYC subway system to study the urban microbiome and create a molecular portrait of NYC. That project 
later led him and Dr. Mason, in 2015, to co-found the MetaSUB (metagenomics of subways and urban biomes) International 
Consortium. Mr. Afshinnekoo currently serves as clinical director for MetaSUB.
“An event such as the COVID-19 pandemic was one of the reasons we founded the consortium, so that we could utilize next-
generation sequencing technology to catalog and characterize urban microbiomes and aid public health officials and clinicians 
with surveillance and tracing,” says Mr. Afshinnekoo. “So when COVID-19 hit, we galvanized our resources to collect samples and 
try to adjust our protocols (which had been DNA-based sampling and analysis) to include RNA in order to detect SARS-CoV-2.” 
Read full article on Ebrahim Afshinnekoo’s work.
Ebrahim Afshinnekoo, left
Salomon Amar, D.D.S., Ph.D. 
NYMC Faculty Member Joins Team to Develop Alternate Form of Ventilation  
For the past several weeks, Albert Kwon, M.D., assistant professor 
of anesthesiology, has taken a step back from his critical role as an 
anesthesiologist at WMC to work on a critically important research project 
with equally lifesaving prospects. 
As the acute need for ventilators amid the COVID-19 health crisis emerged 
and with the potential looming for a shortfall of thousands of units, a group 
of MIT engineers, teaming with doctors with clinical experience in treating 
respiratory conditions, looked to a ten-year-old design for an inexpensive 
alternative for ventilation as the possible solution. The alternate design 
sought to automate the standard manual process of squeezing by hand 
an emergency resuscitator bag (known as an Ambu bag), currently readily 
available in large numbers at hospitals.
Dr. Kwon, an MIT alumnus, first heard about the project during a call to a professional colleague on an unrelated matter 
and was quickly recruited to become part of team. Initially he was tasked with conducting an animal study to validate the 
functionalities of a ventilator. Read full article on the project. 
Nearly $1 Million Grant to Again Support NYMC in Developing Flu Vaccine 
As the COVID-19 pandemic continues, researchers around the world are scrambling to 
develop a vaccine. More than a century ago, the 1918 influenza pandemic, which killed 50 
to 100 million people worldwide, sparked similar vaccine-related research, and today, the 
Centers for Disease Control (CDC) estimates that the influenza vaccine reduces the risk of 
flu illness by between 40 percent and 60 percent. 
NYMC has been at the forefront in aiding in the development of the annual influenza vaccine 
for decades. Each year, NYMC researchers develop two to four high-yield, high-growth 
influenza virus reassortants as ‘seed’ viruses for the production of the world’s annual supply 
of influenza vaccine—some 400 million doses worldwide. 
This year, that research will be supported by a $956,604 grant from the International 
Federation of Pharmaceutical Manufacturers and Associations (IFPMA). Since 2002, NYMC 
has annually received similar funding for influenza vaccine development from IFPMA and the Biomedical Advanced Research 
and Development Authority (BARDA), totaling approximately $18 million to support this important research. 
“Every year is critical, with the influenza vaccine preventing thousands of deaths and several hundred thousand 
hospitalizations,” says Doris J. Bucher, Ph.D., associate professor of microbiology and immunology, who has overseen 
the laboratory and directed the production of the seed viruses at NYMC since 2004. “We also developed the seed viruses 
for the 2009 swine flu vaccine. Because our approach was more rapid than a competing methodology, it resulted in a better 
product, which was recognized by the vaccine manufacturers with increased funding.” Read full article on influenza vaccine 
development.
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GRANTS & DEPARTMENT RESEARCH
Albert Kwon, M.D., center
Doris J. Bucher, Ph.D.
Grants Corner
Mitchell S. Cairo, M.D., professor of pediatrics, medicine, pathology, microbiology and immunology and cell biology 
and anatomy and co-chief of hematology, will serve as PI for a $504,183 grant from Jazz Pharmaceuticals, Inc. for a 
“Pilot Study to Determine the Safety of Defibrotide in Children with High Risk Kawasaki Disease.” 
Abhay Dhand, M.D., associate professor of medicine, has received a $38,750 grant over the course of three years 
from Tetraphase Pharmaceuticals for “In-vitro Susceptibility of Eravacyline Against Multi-Drug Resistant Enterococci and 
Enterobacteriaceae.”
Xiang Dong, M.D., clinical associate professor of surgery, has been awarded a $303,924 grant from The MT Group, 
Inc. for “Translational Medicine: Discovery and Evaluation of Biomarkers/Pharmacogenomics for the Diagnosis and 
Personalized Management of Patients.”
Allen J. Dozor, M.D., professor of pediatrics, has been awarded a $21,205 grant by AstraZeneca Pharmaceuticals to 
conduct a “multicenter, double-blind, randomized, placebo-controlled, parallel group, Phase 3, safety extension study to 
evaluate the safety and tolerability of Tezepelumab in adults and adolescents with severe uncontrolled asthma.”
Marina Holz, Ph.D., dean of the Graduate School of Basic Medical Sciences and professor of cell biology and anatomy, 
has received a $30,000 grant from the American Cancer Society to support “Tamoxifen Signaling in ER-negative Breast 
Cancer.” 
Jeontaik J. Kwon, M.D., M.S.E., assistant professor of surgery, has been awarded a $26,780 grant from Thomas 
Jefferson University in support of “Evaluation of a Closed Incision Negative Pressure Dressing (PREVENA) To Prevent 
Lower Extremity Amputation Wound Complications.” 
Edmund F. Lagamma, M.D. ’76, professor of pediatrics, biochemistry and molecular biology, has been awarded 
a $24,020 grant from Aerogen Pharma for a study to “determine the efficacy, safety and tolerability of AeroFactTM 
(Aerosolized SF-RI 1) administered by nCPAP vs nCPAP alone in treatment of preterm infants at risk for worsening 
respiratory distress syndrome.”
Xiu-Min Li, M.D., M.S., professor of microbiology and immunology and otolaryngology, received a $55,000 grant over 
the course of two years from the Moss Family Foundation for “Mechanisms Underlying the Effects of TCM Dietary 
Supplements on Improving Gastrointestinal Symptoms Related to Eosinophilic Esophagitis:  Preclinical Study.”   
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Student Research Opportunities 
While many NYMC faculty have had to suspend their research activities to prioritize patient care, those not on the front lines 
of the pandemic are able to dedicate more time to student mentoring. In addition, numerous COVID-19-related projects 
have emerged and welcome student involvement. These projects have been met with great enthusiasm as students from 
pre-clinical and clinical years have filled the available spots within days. To help manage the outpouring of student interest, 
student leadership positions have emerged to facilitate medical student contributions during this challenging time. 
Bertie Zhang, a current third-year medical student, has been coordinating and recruiting for COVID-19 research projects 
based at NYC Health + Hospitals/Metropolitan. Through close collaboration with hospital administration, project leads and 
NYMC leadership, she has played a key role in connecting student researchers to multiple projects in the Department of 
Medicine and Department of Emergency Medicine. Current Metropolitan projects include an inpatient COVID-19 database, 
a disposition follow-up QI project and a multicenter COVID-19 study. A survey of all NYMC-affiliated faculty is underway to 
identify all such opportunities for student research. An updated list of available projects (COVID-19-related and non-related) 
for School of Medicine (SOM) students will be posted on LEO/LCMS+ under the SOM-Research heading. In addition, a link to 
the Google sheet will be sent directly to all students. 
Dr. Jonathan Fisher Receives $1.375 million Grant to Study Enhancing 
Sensory Acuity with Ultrasound
Jonathan Fisher, Ph.D., assistant professor of physiology, recently received a four-
year $1.375 million grant from the National Institutes of Health (NIH) to support his 
research on using ultrasound to enhance sensory acuity.
“The surface of our brain, the cerebral cortex, contains a ‘map’ of the senses. This 
map is ‘plastic,’ and can change depending on your experiences. When you practice 
the piano, for example, the regions on your brain that represent the fingers change. 
If a limb is amputated, the topology of the sensory map may change. Noninvasive, 
low-intensity focused ultrasound (FUS) can adjust this mapping—however nobody 
really knows how, why or how far we can take this technology,” says Dr. Fisher. “The 
applications range from therapy to science fiction.”
“Brain stimulation technology is actually a staple of neurotherapeutics. Transcranial magnetic stimulation, for example, 
is ubiquitous and has been used for everything from assessing brain injury to treating depression and eating disorders. 
Deep brain stimulation can be used to treat epilepsy or essential tremor. However, those technologies affect golf ball-sized 
volumes of the brain. Ultrasound can be focused into beams thinner than a grain of rice. Imagine how finely we could tune the 
treatment.” 
According to Dr. Fisher, despite the allure of FUS as a modulation approach, many aspects of the technology relevant to 
translational capability are unclear, and conflicting results have been reported for even macroscopic effects. The federal 
funds, which will support the project, “Neural mechanisms of ultrasound-induced enhancement of sensory acuity,” will allow 
Dr. Fisher to characterize the transformation of targeted stimulation to behavioral changes.
“By leveraging novel optical tools and behavioral experimental approaches, the proposed research will address key 
knowledge gaps that currently limit development and refinement of FUS neuromodulation for use in humans.”
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NYMC Recent Graduate’s Novel Research May Improve Ability to Predict 
Outcomes for Older Neurosurgery Patients
Having authored 18 peer-reviewed publications and having mentored as many as 15 
junior medical students at a time, Matthew McIntyre, M.D. ’20, who graduated in April, 
is poised to become a rising star in the field of neurosurgical research.
Inside the bustling hallways of NYMC, you may have found Matthew McIntyre helping 
a junior medical student to design a study or to review their data set. At first glance, 
it’s an ordinary tableau that can be found in almost any lab at a major health sciences 
college. However, upon closer inspection, what makes this scene extraordinary is that 
at the time, Dr. McIntyre was still just a medical student himself.  
The team Dr. McIntyre is currently mentoring is looking at frailty—a state of reduced physiologic reserve—as a measure to 
predict outcomes in neurosurgical patients. 
Though age and frailty are highly correlated, Dr. McIntyre explains that different studies have shown frailty to be independent 
of age. As a result, current prediction models are not comprehensive enough to give neurosurgeons a definite understanding 
of a patient’s anticipated outcome, but it is Dr. McIntyre’s goal to change that. Read full article about Dr. McIntyre. 
Research Support Services Committee Update
The Research Support Services Committee (RSSC) is a standing 
committee of the NYMC faculty charged with ensuring that research 
services are providing appropriate support to the faculty. Historically, the 
committee has monitored administrative services, such as purchasing 
and research administration, and has worked with other committees 
essential to research activities to improve library and IT services and 
core facilities. The committee also provided key input to the Research 
Advancement Task Force, which was convened by Alan Kadish, M.D., 
president of NYMC and TCUS, in 2011 and developed a focused plan 
for increasing NYMC research and proposed improvements to research 
support processes, several of which have been implemented, including 
overhauling the purchasing system. The RSSC reports to the Executive 
Committee of the Faculty Senate and the NYMC SOM Dean.
At the January meeting, with support from the executive committee and SOM Dean Jerry Nadler, it was agreed to survey the 
faculty to better understand their current and future research needs. After collecting and reworking materials from several 
sources, including the prior Research Task Force survey, the RSSC implemented and launched a new survey on the Qualtrics 
platform with essential contributions from Lenore Carpinelli in the SOM dean’s office.
The survey is now closed, and we thank the many faculty who took their valuable time to contribute. There were 120 
responses from faculty in 21 of 27 basic science and clinical departments in the SOM, Graduate School of Basic Medical 
Sciences and School of Health Sciences and Practice. Survey results are being analyzed, but some preliminary notes of 
interest are:
• Useful suggestions to increase extramural funding successes
• Excellent rating for quality of Laboratory Animal Resources, which is the most-used core
• Good/Average rating for Core Histology Facility, which is second most-used
• Excellent/Good rating for q-PCR facility, which is third most-used
• High level of support for implementing automated monitoring of ultra-freezers, freezers, incubators, etc.
• ~75% of faculty would participate in an automated NYMC network data backup service
Once analyzed, the RSSC will use this information to further improve research operations by following up on issues 
raised, and by making recommendations to the executive committee and Dean Nadler. We will also share the data with other 
divisions as appropriate, with the anticipation these findings will be used for strategic planning.
Reporting for the RSSC, Christopher S. Leonard, Ph.D., chair
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Research Information Updates/NIH Links 
Bridge & Seed Funding Grant Programs: The deadline for submissions of proposals under the Bridge and Seed 
Funding Grant Programs has been extended until May 15, 2020. Special attention will be given to Seed Grant 
applications covering COVID-19. Program guidelines, instructions and application forms are available here. 
Weekly NIH Announcements and NIH Funding Opportunities 
NYMC Office of Research Administration: Learn more about funding opportunities here. 
Research Gate: Read about recent publications here. 
